Almirall

Almirall, S.A.
Company typeSociedad Anónima
BMAD: ALM
ISINES0157097017
Founded1944
FounderAntonio Gallardo Carreras
Headquarters
Ronda del General Mitre, 151
08022 Barcelona
Spain
Area served
International
ProductsEbglyss, Ilumetri, Wynzora, Klisyri, Seysara, Ebastel, Monodox, Acticlate, Almogran, Tesavel & Efficib, Solaraze, Airtal, Decoderm, Cordran, Almax, Parapres, Balneum, Sativex, Cleboril, Monovo, Actikerall.[1]
RevenueIncrease €898.8 million (2023)[2]
Increase €33.5 million (2022)[3]
Total assetsIncrease €2.302 billion (2022)[3]
Number of employees
Decrease 1,904 (2023)[4]
Websitewww.almirall.com

Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.[5]

In 2023, the company generated total revenues of €898.8[6] million and was the leading European company in medical dermatology.

With approximately 1,904 employees (2023), it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA.[7]

  1. ^ Products «Products of Almirall S.A. Archived 5 September 2014 at the Portuguese Web Archive» Retrieved 17 December 2014
  2. ^ "Annual results". 19 February 2024.
  3. ^ a b "Annual financial reports ALMIRALL, S.A." cnmv.es. 19 February 2024. Retrieved 29 March 2024.
  4. ^ "Resultados de Almirall en 2023: Almirall registra un fuerte crecimiento del negocio dermatológico en Europa y avanza en su posición de liderazgo en dermatología médica".
  5. ^ "Almirall | About Almirall | History". www.almirall.com. Archived from the original on 29 September 2018. Retrieved 31 May 2023.
  6. ^ "Almirall annual results". La Vanguardia (in Spanish). 19 February 2024. Retrieved 16 April 2024.
  7. ^ "Estado de información no financiera. Resumen de contenidos".